Search research articles
Contact Us
Filters
Showing results (651-660 of 671) with videos related to
Page
of 68
Sort By:
Journal of Cosmetic Dermatology
|
September 16, 2025
Practical Recommendations for Indians on Sunscreen Use-A Modified Delphi Consensus by Indian Sunscreen Forum (PRISM-ISF)
Malavika Kohli, C R Srinivas, Abir Saraswat, et al.
JACC. Cardiovascular Imaging
|
September 15, 2012
Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions
Jerome L Fleg, Gregg W Stone, Zahi A Fayad, et al.
Journal of Medicinal Chemistry
|
May 14, 2025
Diazepine Agonists of the 5-HT<sub>2C</sub> Receptor with Unprecedented Selectivity: Discovery of Bexicaserin (LP352)
Albert Ren, Xiuwen Zhu, Juerg Lehmann, et al.
Journal of the American Society of Nephrology : JASN
|
May 13, 2018
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation
Julio Pascual, Stefan P Berger, Oliver Witzke, et al.
Transplantation Reviews (Orlando, Fla.)
|
August 5, 2019
Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients
Julio Pascual, Stefan P Berger, Steven J Chadban, et al.
Dermatology and Therapy
|
March 31, 2026
Expert Consensus on the Rational Approach to Isotretinoin Usage for Effective Management of Acne: ERAISE ACNE Recommendations
Sanjiv Kandhari, Jayakar Thomas, Niti Khunger, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1
Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Pharmacology Research & Perspectives
|
August 14, 2020
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer
Krishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, et al.
The Journal of Nutrition
|
November 27, 2009
Nanotechnology research: applications in nutritional sciences
Pothur R Srinivas, Martin Philbert, Tania Q Vu, et al.
Clinical Chemistry
|
September 17, 2013
Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study
Vijay Nambi, Xiaoxi Liu, Lloyd E Chambless, et al.
Page
of 68
Search research articles
Search
Showing results (651-660 of 671) with videos related to
Sort By:
Page
of 68
Journal of Cosmetic Dermatology
|
September 16, 2025
Practical Recommendations for Indians on Sunscreen Use-A Modified Delphi Consensus by Indian Sunscreen Forum (PRISM-ISF)
Malavika Kohli, C R Srinivas, Abir Saraswat, et al.
JACC. Cardiovascular Imaging
|
September 15, 2012
Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions
Jerome L Fleg, Gregg W Stone, Zahi A Fayad, et al.
Journal of Medicinal Chemistry
|
May 14, 2025
Diazepine Agonists of the 5-HT<sub>2C</sub> Receptor with Unprecedented Selectivity: Discovery of Bexicaserin (LP352)
Albert Ren, Xiuwen Zhu, Juerg Lehmann, et al.
Journal of the American Society of Nephrology : JASN
|
May 13, 2018
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation
Julio Pascual, Stefan P Berger, Oliver Witzke, et al.
Transplantation Reviews (Orlando, Fla.)
|
August 5, 2019
Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients
Julio Pascual, Stefan P Berger, Steven J Chadban, et al.
Dermatology and Therapy
|
March 31, 2026
Expert Consensus on the Rational Approach to Isotretinoin Usage for Effective Management of Acne: ERAISE ACNE Recommendations
Sanjiv Kandhari, Jayakar Thomas, Niti Khunger, et al.
Cancer Chemotherapy and Pharmacology
|
July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1
Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Pharmacology Research & Perspectives
|
August 14, 2020
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer
Krishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, et al.
The Journal of Nutrition
|
November 27, 2009
Nanotechnology research: applications in nutritional sciences
Pothur R Srinivas, Martin Philbert, Tania Q Vu, et al.
Clinical Chemistry
|
September 17, 2013
Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study
Vijay Nambi, Xiaoxi Liu, Lloyd E Chambless, et al.
Page
of 68